title: Elbasvir/grazoprevir, Velpatasvir/sofosbuvir, and Eteplirsen.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: William P
authors.initials: WP
authors.lastname: Tidwell
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001572:Benzofurans / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D004338:Drug Combinations; D006526:Hepatitis C / Q000188:drug therapy*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D060172:Morpholinos / Q000627:therapeutic use*; D009136:Muscular Dystrophies / Q000188:drug therapy*; D011810:Quinoxalines / Q000627:therapeutic use*; D000069474:Sofosbuvir / Q000627:therapeutic use*; D001562:Benzimidazoles; D001578:Benzopyrans
chemical_list: D000998:Antiviral Agents; D001572:Benzofurans; D002219:Carbamates; D004338:Drug Combinations; D006576:Heterocyclic Compounds, 4 or More Rings; D007093:Imidazoles; D060172:Morpholinos; D011810:Quinoxalines; D000069474:Sofosbuvir; C000611265:elbasvir-grazoprevir drug combination; C000611335:eteplirsen; C000604171:velpatasvir; D001562:Benzimidazoles; D001578:Benzopyrans